Weekly Investment Analysts’ Ratings Updates for Dolby Laboratories (DLB)

Dolby Laboratories (NYSE: DLB) has recently received a number of price target changes and ratings updates:

• 12/22/2025 – Dolby Laboratories had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/20/2025 – Dolby Laboratories was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 12/15/2025 – Dolby Laboratories had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/8/2025 – Dolby Laboratories had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/1/2025 – Dolby Laboratories had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/22/2025 – Dolby Laboratories was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 11/19/2025 – Dolby Laboratories had its price target lowered by analysts at Rosenblatt Securities from $95.00 to $85.00. They now have a “buy” rating on the stock.
• 11/19/2025 – Dolby Laboratories had its price target lowered by analysts at Barrington Research from $100.00 to $95.00. They now have an “outperform” rating on the stock.
• 11/13/2025 – Dolby Laboratories had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.

Dolby Laboratories Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 10th. Shareholders of record on Tuesday, December 2nd were issued a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, December 2nd. This represents a $1.44 annualized dividend and a yield of 2.2%. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s payout ratio is presently 54.75%.

Insider Buying and Selling

In other Dolby Laboratories news, EVP Mark Andrew Sherman sold 2,491 shares of the stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $67.26, for a total transaction of $167,544.66. Following the sale, the executive vice president directly owned 70,563 shares in the company, valued at $4,746,067.38. This represents a 3.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Kevin J. Yeaman sold 6,751 shares of the firm’s stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $67.24, for a total transaction of $453,937.24. Following the completion of the transaction, the chief executive officer directly owned 98,377 shares in the company, valued at approximately $6,614,869.48. This represents a 6.42% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 162,120 shares of company stock valued at $10,906,559. Company insiders own 37.93% of the company’s stock.

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.